Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease-Reference-Cited by-同舟云学术

Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease

Published:2017-06-13 Issue:12 Volume:58 Page:1977-1983
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Deleye Steven,Waldron Ann-Marie,Verhaeghe Jeroen,Bottelbergs Astrid,Wyffels Leonie,Van Broeck Bianca,Langlois Xavier,Schmidt Mark,Stroobants Sigrid,Staelens Steven

Publisher

Society of Nuclear Medicine

Subject

Radiology Nuclear Medicine and imaging

Reference42 articles.

1. The molecular pathology of Alzheimer's disease

2. Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

3. Peripheral benzodiazepine receptors and mitochondrial function

4. Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

5. Kobayashi N Ueda K Itoh N ., inventors. Shionogi and Co., Ltd., assignee. Pharmaceutical composition for treatment of Alzheimer’s disease. Patent WO2008133273 A1. April 23, 2008.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer’s Disease;Molecular Neurobiology;2024-03-19

2. Relationship between reactive astrocytes, by [¹⁸F]SMBT-1 imaging, with amyloid-beta, tau, glucose metabolism, and microgliosis in mouse models of Alzheimer’s disease;2023-08-22

3. Submillimeter resolution positron emission tomography for high-sensitivity mouse brain imaging;Journal of Nuclear Medicine;2022-12-29

4. PET Imaging in Animal Models of Alzheimer’s Disease;Frontiers in Neuroscience;2022-05-24

5. PET Imaging in Preclinical Anti-Aβ Drug Development;Pharmaceutical Research;2022-05-02